Incyte (INCY) EBITDA (2010 - 2026)
Incyte's EBITDA came in at $724.37 million for Q2 2026, up 30.9% from $553.23 million a year earlier and up 122.9% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) EBITDA (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Incyte reported EBITDA of $1.88 billion, up 47.4% year-over-year; for FY2025, it came in at $1.61 billion, up 967.7% from FY2024.
- Going back by year, EBITDA was $150.61 million in FY2024 (-78.6%), $703.19 million in FY2023 (+8.6%), $647.3 million in FY2022 (+0.6%) and $643.62 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBITDA in data going back to Q1 2010.
- Year-over-year, EBITDA has increased for four consecutive quarters, with growth averaging 55.5% over the last seven quarters.
- The fastest year-over-year change in EBITDA over five years came in Q3 2025 (growth of 177.3%), and the weakest in Q1 2023 (a decline of 66.9%).
- Business Quant data shows INCY's EBITDA at $324.92 million (Q1 2026), $359.84 million (Q4 2025) and $467.54 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn | 724.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 724.37 Mn |
| Mar 31, 2026 | 324.92 Mn |
| Dec 31, 2025 | 359.84 Mn |
| Sep 30, 2025 | 467.54 Mn |
| Jun 30, 2025 | 553.23 Mn |
| Mar 31, 2025 | 227.53 Mn |
| Dec 31, 2024 | 324.25 Mn |
| Sep 30, 2024 | 168.61 Mn |
| Jun 30, 2024 | -456.08 Mn |
| Mar 31, 2024 | 113.85 Mn |
| Dec 31, 2023 | 209.03 Mn |
| Sep 30, 2023 | 236.10 Mn |
| Jun 30, 2023 | 214.08 Mn |
| Mar 31, 2023 | 43.98 Mn |
| Dec 31, 2022 | 88.31 Mn |
| Sep 30, 2022 | 155.07 Mn |
| Jun 30, 2022 | 270.94 Mn |
| Mar 31, 2022 | 132.98 Mn |
| Dec 31, 2021 | 125.59 Mn |
| Sep 30, 2021 | 250.10 Mn |
API Access
Incyte EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();